ETF Partners’ new Q&A on Medium is now live!
In our latest chat, we speak with Anthony Finbow, CEO of Eagle Genomics, the software platform supporting organisations to solve the grand challenges in life sciences.
With an early career covering engineering, law, and finance, he has spent the last twenty years building and running technology businesses in a variety of sectors.
In this feature, Anthony shares his thoughts on the future of the business and specifically the ambition to harness microbiome science to secure a sustainable future.
Read more on our Medium page!